{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:10:33Z","timestamp":1792239033024,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04031-1","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T15:29:22Z","timestamp":1745508562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis"],"prefix":"10.1007","volume":"74","author":[{"given":"Shifeng","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"1","key":"4031_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12885-021-08280-y","volume":"21","author":"L Zhou","year":"2021","unstructured":"Zhou L et al (2021) Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer 21(1):606","journal-title":"BMC Cancer"},{"issue":"1","key":"4031_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F et al (2024) Multiple myeloma. Nat Rev Dis Primers 10(1):45","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"4031_CR3","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.3390\/curroncol29110705","volume":"29","author":"M Ho","year":"2022","unstructured":"Ho M et al (2022) Treating multiple myeloma in the context of the bone marrow microenvironment. Curr Oncol 29(11):8975\u20139005","journal-title":"Curr Oncol"},{"issue":"4","key":"4031_CR4","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1172\/JCI129205","volume":"130","author":"SA Minnie","year":"2020","unstructured":"Minnie SA, Hill GR (2020) Immunotherapy of multiple myeloma. J Clin Invest 130(4):1565\u20131575","journal-title":"J Clin Invest"},{"key":"4031_CR5","doi-asserted-by":"publisher","first-page":"909880","DOI":"10.3389\/fimmu.2022.909880","volume":"13","author":"R Lopes","year":"2022","unstructured":"Lopes R et al (2022) Multiple myeloma-derived extracellular vesicles modulate the bone marrow immune microenvironment. Front Immunol 13:909880","journal-title":"Front Immunol"},{"issue":"2","key":"4031_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cancers13020217","volume":"13","author":"A Garc\u00eda-Ortiz","year":"2021","unstructured":"Garc\u00eda-Ortiz A et al (2021) The role of tumor microenvironment in multiple myeloma development and progression. Cancers 13(2):217","journal-title":"Cancers"},{"issue":"19","key":"4031_CR7","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.4161\/cc.26193","volume":"12","author":"DK Walters","year":"2013","unstructured":"Walters DK, Arendt BK, Jelinek DF (2013) CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells. Cell Cycle 12(19):3175\u20133183","journal-title":"Cell Cycle"},{"issue":"3","key":"4031_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/ijms24032606","volume":"24","author":"C Chelakkot","year":"2023","unstructured":"Chelakkot C et al (2023) Modulating glycolysis to improve cancer therapy. Int J Mol Sci 24(3):2606","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4031_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","volume":"77","author":"J Yang","year":"2020","unstructured":"Yang J et al (2020) The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci 77(2):305\u2013321","journal-title":"Cell Mol Life Sci"},{"key":"4031_CR10","doi-asserted-by":"publisher","first-page":"1015402","DOI":"10.3389\/fonc.2022.1015402","volume":"12","author":"V Raimondi","year":"2022","unstructured":"Raimondi V et al (2022) Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease. Front Oncol 12:1015402","journal-title":"Front Oncol"},{"issue":"4","key":"4031_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/ijms19041200","volume":"19","author":"C El Arfani","year":"2018","unstructured":"El Arfani C et al (2018) Metabolic features of multiple myeloma. Int J Mol Sci 19(4):1200","journal-title":"Int J Mol Sci"},{"key":"4031_CR12","doi-asserted-by":"publisher","first-page":"591342","DOI":"10.3389\/fonc.2020.591342","volume":"10","author":"S Wu","year":"2020","unstructured":"Wu S et al (2020) Metabolic reprogramming induces immune cell dysfunction in the tumor microenvironment of multiple myeloma. Front Oncol 10:591342","journal-title":"Front Oncol"},{"key":"4031_CR13","doi-asserted-by":"publisher","first-page":"3119375","DOI":"10.1155\/2022\/3119375","volume":"2022","author":"Y Gao","year":"2022","unstructured":"Gao Y et al (2022) Tumor microenvironment: lactic acid promotes tumor development. J Immunol Res 2022:3119375","journal-title":"J Immunol Res"},{"key":"4031_CR14","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms21218363","volume":"21","author":"JX Wang","year":"2020","unstructured":"Wang JX et al (2020) Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. Int J Mol Sci 21:8363","journal-title":"Int J Mol Sci"},{"issue":"7519","key":"4031_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513(7519):559\u2013563","journal-title":"Nature"},{"issue":"3","key":"4031_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H et al (2022) Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis 13(3):206","journal-title":"Cell Death Dis"},{"issue":"4","key":"4031_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu X et al (2018) Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle 17(4):428\u2013438","journal-title":"Cell Cycle"},{"issue":"1","key":"4031_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41392-023-01320-y","volume":"8","author":"K Wang","year":"2023","unstructured":"Wang K, Zhang Y, Chen ZN (2023) Metabolic interaction: tumor-derived lactate inhibiting CD8(+) T cell cytotoxicity in a novel route. Signal Transduct Target Ther 8(1):52","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4031_CR19","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1038\/s41598-023-35793-2","volume":"13","author":"B Yan","year":"2023","unstructured":"Yan B et al (2023) A pan-cancer analysis of the role of USP5 in human cancers. Sci Rep 13(1):8972","journal-title":"Sci Rep"},{"issue":"9","key":"4031_CR20","doi-asserted-by":"publisher","first-page":"e3058","DOI":"10.1038\/cddis.2017.450","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S et al (2017) Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. Cell Death Dis 8(9):e3058","journal-title":"Cell Death Dis"},{"issue":"1","key":"4031_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/jcb.29309","volume":"121","author":"L Wu","year":"2020","unstructured":"Wu L et al (2020) miR-125a suppresses malignancy of multiple myeloma by reducing the deubiquitinase USP5. J Cell Biochem 121(1):642\u2013650","journal-title":"J Cell Biochem"},{"issue":"12","key":"4031_CR22","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41401-019-0249-1","volume":"40","author":"XH Chen","year":"2019","unstructured":"Chen XH et al (2019) Mebendazole elicits potent antimyeloma activity by inhibiting the USP5\/c-Maf axis. Acta Pharmacol Sin 40(12):1568\u20131577","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"4031_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13058-024-01767-z","volume":"26","author":"ZM Peng","year":"2024","unstructured":"Peng ZM et al (2024) PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. Breast Cancer Res 26(1):10","journal-title":"Breast Cancer Res"},{"issue":"3","key":"4031_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cac2.12403","volume":"43","author":"P Xia","year":"2023","unstructured":"Xia P et al (2023) METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Commun 43(3):338\u2013364","journal-title":"Cancer Commun"},{"issue":"43","key":"4031_CR25","doi-asserted-by":"publisher","first-page":"70481","DOI":"10.18632\/oncotarget.12026","volume":"7","author":"LJ Crawford","year":"2016","unstructured":"Crawford LJ et al (2016) Identification of the APC\/C co-factor FZR1 as a novel therapeutic target for multiple myeloma. Oncotarget 7(43):70481\u201370493","journal-title":"Oncotarget"},{"issue":"2","key":"4031_CR26","doi-asserted-by":"publisher","first-page":"111846","DOI":"10.1016\/j.yexcr.2020.111846","volume":"388","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li S (2020) Lactic acid promotes macrophage polarization through MCT-HIF1\u03b1 signaling in gastric cancer. Exp Cell Res 388(2):111846","journal-title":"Exp Cell Res"},{"issue":"6","key":"4031_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00006676-198611000-00002","volume":"1","author":"P Layer","year":"1986","unstructured":"Layer P, Hotz J, Goebell H (1986) Stimulatory effect of hypercalcemia on pancreatic secretion is prevented by pretreatment with cholecystokinin and cholinergic agonists. Pancreas 1(6):478\u2013482","journal-title":"Pancreas"},{"issue":"5","key":"4031_CR28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1074\/mcp.RA119.001390","volume":"18","author":"L Janker","year":"2019","unstructured":"Janker L et al (2019) Metabolic, anti-apoptotic and immune evasion strategies of primary human myeloma cells indicate adaptations to hypoxia. Mol Cell Proteomics 18(5):936\u2013953","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"4031_CR29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ajh.26577","volume":"97","author":"LA Evans","year":"2022","unstructured":"Evans LA et al (2022) Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma. Am J Hematol 97(7):895\u2013902","journal-title":"Am J Hematol"},{"key":"4031_CR30","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jconrel.2023.05.024","volume":"358","author":"P Zhao","year":"2023","unstructured":"Zhao P et al (2023) Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery. J Control Release 358:706\u2013717","journal-title":"J Control Release"},{"issue":"1","key":"4031_CR31","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X et al (2023) ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun 14(1):2859","journal-title":"Nat Commun"},{"issue":"3","key":"4031_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cac2.12274","volume":"42","author":"Z Wang","year":"2022","unstructured":"Wang Z et al (2022) The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun 42(3):245\u2013265","journal-title":"Cancer Commun"},{"issue":"1","key":"4031_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/cac2.12380","volume":"43","author":"Y Yang","year":"2023","unstructured":"Yang Y et al (2023) circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer. Cancer Commun 43(1):100\u2013122","journal-title":"Cancer Commun"},{"issue":"34","key":"4031_CR34","doi-asserted-by":"publisher","first-page":"e2403235121","DOI":"10.1073\/pnas.2403235121","volume":"121","author":"W Ren","year":"2024","unstructured":"Ren W et al (2024) Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2. Proc Natl Acad Sci U S A 121(34):e2403235121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4031_CR35","doi-asserted-by":"publisher","first-page":"1331731","DOI":"10.3389\/fimmu.2024.1331731","volume":"15","author":"CE Espada","year":"2024","unstructured":"Espada CE et al (2024) ISG15\/USP18\/STAT2 is a molecular hub regulating IFN I-mediated control of Dengue and Zika virus replication. Front Immunol 15:1331731","journal-title":"Front Immunol"},{"key":"4031_CR36","doi-asserted-by":"publisher","first-page":"156081","DOI":"10.1016\/j.cyto.2022.156081","volume":"161","author":"J Canar","year":"2023","unstructured":"Canar J et al (2023) The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance. Cytokine 161:156081","journal-title":"Cytokine"},{"issue":"4","key":"4031_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1046\/j.1365-2141.2000.02127.x","volume":"109","author":"J De Vos","year":"2000","unstructured":"De Vos J et al (2000) JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol 109(4):823\u2013828","journal-title":"Br J Haematol"},{"issue":"23","key":"4031_CR38","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1111\/febs.16058","volume":"288","author":"EN Vandsemb","year":"2021","unstructured":"Vandsemb EN et al (2021) PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1\/2. Febs j 288(23):6700\u20136715","journal-title":"Febs j"},{"issue":"23","key":"4031_CR39","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.1111\/febs.16120","volume":"288","author":"CN Smith","year":"2021","unstructured":"Smith CN, Blackburn JS (2021) PRL-3 promotes a positive feedback loop between STAT1\/2-induced gene expression and glycolysis in multiple myeloma. Febs j 288(23):6674\u20136676","journal-title":"Febs j"},{"issue":"10","key":"4031_CR40","doi-asserted-by":"publisher","first-page":"111756","DOI":"10.1016\/j.celrep.2022.111756","volume":"41","author":"T Dai","year":"2022","unstructured":"Dai T et al (2022) Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Cell Rep 41(10):111756","journal-title":"Cell Rep"},{"issue":"1","key":"4031_CR41","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s12885-022-09636-8","volume":"22","author":"W Wang","year":"2022","unstructured":"Wang W, Wang B (2022) KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development. BMC Cancer 22(1):562","journal-title":"BMC Cancer"},{"issue":"6","key":"4031_CR42","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1080\/01443615.2022.2062225","volume":"42","author":"Y Wu","year":"2022","unstructured":"Wu Y et al (2022) Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK\/ERK\/c-Myc pathway in cervical cancer cells. J Obstet Gynaecol 42(6):2399\u20132405","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"4031_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/dgd.12645","volume":"62","author":"H Lu","year":"2020","unstructured":"Lu H et al (2020) PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer. Dev Growth Differ 62(2):129\u2013138","journal-title":"Dev Growth Differ"},{"issue":"1","key":"4031_CR44","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1038\/s41598-023-43619-4","volume":"13","author":"X Gu","year":"2023","unstructured":"Gu X et al (2023) Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients. Sci Rep 13(1):16284","journal-title":"Sci Rep"},{"key":"4031_CR45","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.2147\/IJGM.S369126","volume":"15","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism. Int J Gen Med 15:6341\u20136353","journal-title":"Int J Gen Med"},{"issue":"9","key":"4031_CR46","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41419-022-05241-6","volume":"13","author":"C Lu","year":"2022","unstructured":"Lu C et al (2022) Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis. Cell Death Dis 13(9):790","journal-title":"Cell Death Dis"},{"key":"4031_CR47","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20230677","author":"S Kar","year":"2023","unstructured":"Kar S et al (2023) Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20230677"},{"issue":"6","key":"4031_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00432-024-05849-5","volume":"150","author":"Y Gu","year":"2024","unstructured":"Gu Y et al (2024) Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma. J Cancer Res Clin Oncol 150(6):311","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"4031_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40364-022-00376-2","volume":"10","author":"S Okabe","year":"2022","unstructured":"Okabe S, Tanaka Y, Gotoh A (2022) Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions. Biomark Res 10(1):31","journal-title":"Biomark Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04031-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:03:15Z","timestamp":1747663395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04031-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4031"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04031-1","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20230677","asserted-by":"subject"}]},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The collection and use of clinical specimens were approved by the ethics committee of The Affiliated Hospital of Jinggangshan University and performed in accordance with the Declaration of Helsinki. All subjects were provided written informed consent.The animal experiment was approved by the Animal Ethics Committee of The Affiliated Hospital of Jinggangshan University. All the animal procedures were performed in accordance with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"180"}}